About the Event The Indian Pharma Industry faces a myriad of challenges when it comes to ensuring the quality and compliance of computer software used in manufacturing processes. With stringent regulatory requirements, evolving technologies, and the increasing complexity of software systems, industry professionals are constantly seeking solutions to navigate these challenges effectively.
Knight Therapeutics Inc. specialty pharmaceutical company, announced today that Knight's New Drug Submission (NDS) for CREXONT® has been accepted for review by Health Canada.
To conduct research work assigned by the PI and assist in various phases of research project. Candidate with proficiency in microbial fermentation, nanomaterial synthesis and polymer research is preferrable.
Should have hands on experience in Water samples analysis, In-process Bioburden and BET analysis, MLT analysis of Raw material and packing material, Antibiotic assay by Microbial method.
Review of analytical documents with relevant Raw Data, protocols, and Report Etc. Review of tending of the testing of Raw material, Finished Products, Stability samples & Raw materials
In a strategic move signaling its growing ambitions, Corona Remedies has acquired seven well-established pharmaceutical brands from Bayer’s Indian portfolio. The acquisition, effective July 16, 2025, includes one cardiology product and six widely used brands in the women’s health and fertility space.